Stephen Maxted Ansell, MD, PhD

  • 20991 Citations
  • 77 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

2015
12 Citations (Scopus)

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: A randomized, double-blind, placebo-controlled phase 2b trial

Fayad, L., Ansell, S. M., Advani, R., Coiffier, B., Stuart, R., Bartlett, N. L., Forero-Torres, A., Kuliczkowski, K., Belada, D., Ng, E. & Drachman, J. G., Sep 2 2015, In : Leukemia and Lymphoma. 56, 9, p. 2569-2578 10 p.

Research output: Contribution to journalArticle

Salvage Therapy
Ifosfamide
Lymphoma, Large B-Cell, Diffuse
Carboplatin
Vincristine
3 Citations (Scopus)

DNA methylation in lymphoma: An opportunity?

Ansell, S. M., Mar 19 2015, In : Blood. 125, 12, p. 1848-1849 2 p.

Research output: Contribution to journalArticle

DNA Methylation
Lymphoma
Methylation
DNA Fingerprinting
Epigenomics
131 Citations (Scopus)

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Gopal, A. K., Chen, R., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Connors, J. M., Engert, A., Larsen, E. K., Chi, X., Sievers, E. L. & Younes, A., Feb 19 2015, In : Blood. 125, 8, p. 1236-1243 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Refractory materials
Transplants
Stem cells
Disease control
9 Citations (Scopus)

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

Zent, C. S., Call, T. G., Bowen, D. A., Conte, M. J., LaPlant, B. R., Witzig, T. E., Ansell, S. M. & Weiner, G. J., Aug 3 2015, In : Leukemia and Lymphoma. 56, 8, p. 2373-2378 6 p.

Research output: Contribution to journalArticle

beta-Glucans
B-Cell Chronic Lymphocytic Leukemia
Confidence Intervals
Therapeutics
Phase II Clinical Trials
21 Citations (Scopus)

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma

Mir, M. A., Maurer, M. J., Ziesmer, S. C., Slager, S. L., Habermann, T. M., Macon, W. R., Link, B. K., Syrbu, S., Witzig, T. E., Friedberg, J. W., Press, O., LeBlanc, M., Cerhan, J. R., Novak, A. J. & Ansell, S. M., Feb 5 2015, In : Blood. 125, 6, p. 992-998 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Chemotherapy
Interleukin-1 Receptors
Cytokines
Oncology
4 Citations (Scopus)

Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Oct 3 2015, In : Expert Review of Anticancer Therapy. 15, 10, p. 1143-1156 14 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Lymphoma
Mutation
Therapeutics
Non-Hodgkin's Lymphoma
4 Citations (Scopus)

Expression of the chemokine receptor gene, CCR8, is associated with DUSP22 rearrangements in anaplastic large cell lymphoma

Xing, X., Flotte, T. J., Law, M. E., Blahnik, A. J., Chng, W. J., Huang, G., Knudson, R. A., Ketterling, R. P., Porcher, J. C., Ansell, S. M., Sidhu, J., Dogan, A. & Feldman, A. L., Sep 23 2015, In : Applied Immunohistochemistry and Molecular Morphology. 23, 8, p. 580-589 10 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Chemokine Receptors
Skin
Genes
In Situ Hybridization
11 Citations (Scopus)

Genome-Wide association study of event-free survival in diffuse large B-cell lymphoma treated with immunochemotherapy

Ghesquieres, H., Slager, S. L., Jardin, F., Veron, A. S., Asmann, Y., Maurer, M. J., Fest, T., Habermann, T. M., Bene, M. C., Novak, A. J., Mareschal, S., Haioun, C., Lamy, T., Ansell, S. M., Tilly, H., Witzig, T. E., Weiner, G. J., Feldman, A. L., Dogan, A., Cunningham, J. M. & 7 others, Olswold, C. L., Molina, T. J., Link, B. K., Milpied, N., Cox, D. G., Salles, G. A. & Cerhan, J. R., Nov 20 2015, In : Journal of Clinical Oncology. 33, 33, p. 3930-3937 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Genome-Wide Association Study
Disease-Free Survival
Single Nucleotide Polymorphism
Survival
43 Citations (Scopus)

Hodgkin lymphoma: Diagnosis and treatment

Ansell, S. M., 2015, In : Mayo Clinic Proceedings. 90, 11, p. 1574-1583 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Stem Cells
Therapeutics
Transplants
Drug Therapy
2 Citations (Scopus)

Hodgkin's lymphoma

Younes, A., Carbone, A., Johnson, P., Dabaja, B., Ansell, S. M. & Kuruvilla, J., Jan 7 2015, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology: Tenth Edition. Wolters Kluwer Health Adis (ESP)

Research output: Chapter in Book/Report/Conference proceedingChapter

Hodgkin Disease
10 Citations (Scopus)

Ibrutinib for the treatment of Waldenström macroglobulinemia

Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Sep 3 2015, In : Expert Review of Hematology. 8, 5, p. 569-579 11 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Paraproteinemias
Poisons
B-Cell Lymphoma
Therapeutics
31 Citations (Scopus)

IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma

Xiu, B., Lin, Y., Grote, D. M., Ziesmer, S. C., Gustafson, M., Maas, M. L., Zhang, Z., Dietz, A. B., Porrata, L. F., Novak, A. J., Liang, A. B., Yang, Z. Z. & Ansell, S. M., Jul 31 2015, In : Blood Cancer Journal. 5, 7, e328.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Immunosuppressive Agents
Interleukin-10
Non-Hodgkin's Lymphoma
Monocytes
7 Citations (Scopus)

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma

Porrata, L. F., Burgstaler, E. A., Winters, J. L., Jacob, E. K., Gastineau, D. A., Suman, V. J., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nevala, W. & Markovic, S. N., Sep 23 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Autografts
Lymphocyte Count
Non-Hodgkin's Lymphoma
Survival
Peripheral Blood Stem Cell Transplantation
3 Citations (Scopus)
Peripheral Blood Stem Cell Transplantation
T-Cell Lymphoma
Hematopoietic Stem Cell Transplantation
Autografts
Monocytes
7 Citations (Scopus)

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Feb 2 2015, In : Journal of Blood Medicine. 6, p. 45-53 9 p.

Research output: Contribution to journalArticle

Autografts
Hodgkin Disease
Monocytes
Lymphocytes
Survival
194 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Phenotype
Germinal Center
Disease-Free Survival
27 Citations (Scopus)

Non-Hodgkin Lymphoma: Diagnosis and Treatment

Ansell, S. M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1152-1163 12 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Therapeutics
Hematopoietic System
Lymphoma
Radiotherapy
2 Citations (Scopus)

Non-Hodgkin lymphoma, body mass index, and cytokine polymorphisms: A pooled analysis from the interlymph consortium

Kane, E., Skibola, C. F., Bracci, P. M., Cerhan, J. R., Costas, L., Smedby, K. E., Holly, E. A., Maynadié, M., Novak, A. J., Lightfoot, T. J., Ansell, S. M., Smith, A. G., Liebow, M., Melbye, M., Morton, L., De Sanjosé, S., Slager, S. L., Wang, S. S., Zhang, Y., Zheng, T. & 1 others, Roman, E., Jul 1 2015, In : Cancer Epidemiology Biomarkers and Prevention. 24, 7, p. 1061-1070 10 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Body Mass Index
Lymphoma, Large B-Cell, Diffuse
Obesity
B-Cell Chronic Lymphocytic Leukemia
1 Citation (Scopus)
Hodgkin Disease
Reed-Sternberg Cells
Drug Therapy
Tumor Microenvironment
Antibodies
1676 Citations (Scopus)

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., Rodig, S. J., Chapuy, B., Ligon, A. H., Zhu, L., Grosso, J. F., Kim, S. Y. O., Timmerman, J. M., Shipp, M. A. & Armand, P., Jan 22 2015, In : The New England journal of medicine. 372, 4, p. 311-319 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Reed-Sternberg Cells
Janus Kinases
Stem Cell Transplantation
Drug-Related Side Effects and Adverse Reactions
61 Citations (Scopus)

PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

Yang, Z. Z., Grote, D. M., Ziesmer, S. C., Xiu, B., Novak, A. J. & Ansell, S. M., Jan 1 2015, In : Blood Cancer Journal. 5, 2, e281.

Research output: Contribution to journalArticle

Follicular Lymphoma
T-Lymphocytes
Survival
Population
Phenotype

Phase II clinical trials for Waldenstrom's macroglobulinemia

Chakraborty, R., Ansell, S. M., Kapoor, P. & Gertz, M., May 1 2015, In : Expert Opinion on Orphan Drugs. 3, 5, p. 537-547 11 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Phase II Clinical Trials
Proteasome Inhibitors
Sirolimus
Phosphatidylinositol 3-Kinases
10 Citations (Scopus)

Survival in patients with limited-stage peripheral T-cell lymphomas

Briski, R., Feldman, A. L., Bailey, N. G., Lim, M. S., Ristow, K., Habermann, T. M., Macon, W. R., Inwards, D. J., Colgan, J. P., Nowakowski, G. S., Kaminski, M. S., Witzig, T. E., Ansell, S. M. & Wilcox, R. A., Jun 1 2015, In : Leukemia and Lymphoma. 56, 6, p. 1665-1670 6 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Survival
Anaplastic Large-Cell Lymphoma
T-Cell Lymphoma
Hematopoietic Stem Cells
28 Citations (Scopus)
Waldenstrom Macroglobulinemia
Apoptosis
Proteasome Endopeptidase Complex
Neoplasms
Ubiquitinated Proteins
27 Citations (Scopus)

Targeting immune checkpoints in lymphoma

Ansell, S. M., Jul 1 2015, In : Current Opinion in Hematology. 22, 4, p. 337-342 6 p.

Research output: Contribution to journalArticle

Lymphoma
Hodgkin Disease
CD274 Antigen
Cell Death
Tumor Microenvironment
8 Citations (Scopus)

Targeting the spleen tyrosine kinase with fostamatinib as a strategy against Waldenström Macroglobulinemia

Kuiatse, I., Baladandayuthapani, V., Lin, H. Y., Thomas, S. K., Bjorklund, C. C., Weber, D. M., Wang, M., Shah, J. J., Zhang, X. D., Jones, R. J., Ansell, S. M., Yang, G., Treon, S. P. & Orlowski, R. Z., Jun 1 2015, In : Clinical Cancer Research. 21, 11, p. 2538-2545 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Mitogen-Activated Protein Kinase Kinases
Mitogen-Activated Protein Kinase 3
Clonal Evolution
Cell Line
8 Citations (Scopus)

T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: Activation, suppression and exhaustion

Yang, Z. Z., Liang, A. B. & Ansell, S. M., Sep 2 2015, In : Leukemia and Lymphoma. 56, 9, p. 2498-2504 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Cellular Immunity
Non-Hodgkin's Lymphoma
T-Lymphocytes
Lymphoma

The era of immuno-oncology: are we there yet?

Villasboas Bisneto, J. J. C. . & Ansell, S. M., Mar 1 2015, In : Oncology (Williston Park, N.Y.). 29, 3, p. 204-205 2 p.

Research output: Contribution to journalComment/debate

The era of immuno-oncology: Are we there yet?

Villasboas Bisneto, J. J. C. . & Ansell, S. M., Mar 15 2015, In : ONCOLOGY (United States). 29, 3

Research output: Contribution to journalArticle

The era of immuno-oncology: are we there yet?

Villasboas, J. C. & Ansell, S. M., Mar 1 2015, In : Oncology (Williston Park, N.Y.). 29, 3, p. 204-205 2 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Biological Products
Antineoplastic Agents
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
44 Citations (Scopus)

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

Witzig, T. E., Reeder, C., Han, J. J., LaPlant, B., Stenson, M., Tun, H. W., Macon, W., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S. & Gupta, M., Jul 16 2015, In : Blood. 126, 3, p. 328-335 8 p.

Research output: Contribution to journalArticle

T-cells
T-Cell Lymphoma
Tumors
Sirolimus
Confidence Intervals
24 Citations (Scopus)

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

Luchtel, R., Kip, N. S., Xing, X., Zeng, Y., Yang, Z. Z., Lee, J. H., Almada, L. L., Elsawa, S. F., Knudson, R. A., Law, M. E., Ketterling, R. P., Cunningham, J. M., Wu, Y., Maurer, M. J., O'Byrne, M. M., Cerhan, J. R., Slager, S. L., Link, B. K., Porcher, J. C., Grote, D. M. & 5 others, Jelinek, D. F., Dogan, A., Ansell, S. M., Fernandez-Zapico, M. E. & Feldman, A. L., May 14 2015, In : Blood. 125, 20, p. 3118-3127 10 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
T-cells
Transcription Factors
Feedback
interferon regulatory factor-4
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Therapeutics
Antigen Receptors
Antibodies
8 Citations (Scopus)

Waldenström macroglobulinemia

Kasi, P. M., Ansell, S. M. & Gertz, M., 2015, In : Clinical Advances in Hematology and Oncology. 13, 1, p. 56-66 11 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Therapeutics
Cladribine
Chlorambucil
Alkylating Agents
2 Citations (Scopus)

Waldenström macroglobulinemia and autoimmunity: What's the connection?

Ansell, S. M., Apr 1 2015, In : Leukemia and Lymphoma. 56, 4, p. 845-846 2 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Pure Red-Cell Aplasia
Waldenstrom Macroglobulinemia
Autoimmunity
32 Citations (Scopus)

Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapytreated diffuse large B-cell lymphoma

Novak, A. J., Asmann, Y., Maurer, M. J., Wang, C., Slager, S. L., Hodge, L. S., Manske, M., Price-Troska, T., Yang, Z. Z., Zimmermann, M. T., Nowakowski, G. S., Ansell, S. M., Witzig, T. E., McPhail, E., Ketterling, R., Feldman, A. L., Dogan, A., Link, B. K., Habermann, T. M. & Cerhan, J. R., Aug 14 2015, In : Blood Cancer Journal. 5, 8, e346.

Research output: Contribution to journalArticle

Exome
Lymphoma, Large B-Cell, Diffuse
Doxorubicin
Mutation
Genes
2014
3 Citations (Scopus)

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

Ehlers, S. L., Bronars, C. A., Patten, C. A., Brockman, T., Hughes, C., Decker, P. A., Cerhan, J. R., Hogan, W., Dispenzieri, A., Ansell, S. M., Ebbert, J. O. & Gastineau, D., 2014, In : Bone Marrow Transplantation. 49, 7, p. 961-965 5 p.

Research output: Contribution to journalArticle

Tobacco Use
Cotinine
Serum
Sensitivity and Specificity
Secondary Prevention
48 Citations (Scopus)

Activation of TAK1 by MYD88 L265P drives malignant B-cell growth in non-Hodgkin lymphoma

Ansell, S. M., Hodge, L. S., Secreto, F. J., Manske, M., Braggio, E. D., Price-Troska, T., Ziesmer, S., Li, Y., Johnson, S. H., Hart, S., Kocher, J-P., Vasmatzis, G., Chanan Khan, A. A., Gertz, M., Fonseca, R., Dogan, A., Cerhan, J. R. & Novak, A. J., 2014, In : Blood Cancer Journal. 4, 2, 20144.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Non-Hodgkin's Lymphoma
B-Lymphocytes
Growth
TNF Receptor-Associated Factor 6
159 Citations (Scopus)

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Parrilla Castellar, E. R., Jaffe, E. S., Said, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., Vasmatzis, G., Gibson, S. E., Ondrejka, S., Nicolae, A., Grogg, K. L., Allmer, C., Ristow, K. M., Wilson, W. H., Macon, W. R., Law, M. E. & 6 others, Cerhan, J. R., Habermann, T. M., Ansell, S. M., Dogan, A., Maurer, M. J. & Feldman, A. L., Aug 28 2014, In : Blood. 124, 9, p. 1473-1480 8 p., 1284.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
anaplastic lymphoma kinase
Clinical Pathology
Chemotherapy
T-cells
43 Citations (Scopus)

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Cozen, W., Timofeeva, M. N., Li, D., Diepstra, A., Hazelett, D., Delahaye-Sourdeix, M., Edlund, C. K., Franke, L., Rostgaard, K., Van Den Berg, D. J., Cortessis, V. K., Smedby, K. E., Glaser, S. L., Westra, H. J., Robison, L. L., Mack, T. M., Ghesquieres, H., Hwang, A. E., Nieters, A., De Sanjose, S. & 47 others, Lightfoot, T., Becker, N., Maynadie, M., Foretova, L., Roman, E., Benavente, Y., Rand, K. A., Nathwani, B. N., Glimelius, B., Staines, A., Boffetta, P., Link, B. K., Kiemeney, L., Ansell, S. M., Bhatia, S., Strong, L. C., Galan, P., Vatten, L., Habermann, T. M., Duell, E. J., Lake, A., Veenstra, R. N., Visser, L., Liu, Y., Urayama, K. Y., Montgomery, D., Gaborieau, V., Weiss, L. M., Byrnes, G., Lathrop, M., Cocco, P., Best, T., Skol, A. D., Adami, H. O., Melbye, M., Cerhan, J. R., Gallagher, A., Taylor, G. M., Slager, S. L., Brennan, P., Coetzee, G. A., Conti, D. V., Onel, K., Jarrett, R. F., Hjalgrim, H., Van Den Berg, A. & McKay, J. D., Jun 12 2014, In : Nature Communications. 5, 3856.

Research output: Contribution to journalArticle

loci
Hodgkin Disease
Meta-Analysis
Genes
magnetic permeability
34 Citations (Scopus)

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

De Vos, S., Forero-Torres, A., Ansell, S. M., Kahl, B., Cheson, B. D., Bartlett, N. L., Furman, R. R., Winter, J. N., Kaplan, H., Timmerman, J., Whiting, N. C., Drachman, J. G. & Advani, R., Jun 12 2014, In : Journal of Hematology and Oncology. 7, 1, 44.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Safety
Chills
Lymphopenia
Conjunctivitis
18 Citations (Scopus)

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

Paulus, A., Chitta, K., Akhtar, S., Personett, D., Miller, K. C., Thompson, K. J., Carr, J., Kumar, S. K., Roy, V., Ansell, S. M., Mikhael, J. R., Dispenzieri, A., Reeder, C. B., Rivera, C. E., Foran, J. M. & Chanan Khan, A. A., Feb 2014, In : British Journal of Haematology. 164, 3, p. 352-365 14 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Multiple Myeloma
Dexamethasone
Plasma Cells
Down-Regulation
5 Citations (Scopus)

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

Secreto, F., Manske, M., Price-Troska, T., Ziesmer, S., Hodge, L. S., Ansell, S. M., Cerhan, J. R. & Novak, A. J., 2014, In : Leukemia and Lymphoma. 55, 8, p. 1884-1892 9 p.

Research output: Contribution to journalArticle

B-Cell Activation Factor Receptor
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
Interleukin-4 Receptors
B-Cell Lymphoma
Phosphatidylinositols
50 Citations (Scopus)

Brentuximab vedotin

Ansell, S. M., Nov 20 2014, In : Blood. 124, 22, p. 3197-3200 4 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Chemotherapy
Hodgkin Disease
Toxicity
Anti-Idiotypic Antibodies
11 Citations (Scopus)

Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenström's macroglobulinemia

Hodge, L. S., Ziesmer, S. C., Yang, Z. Z., Secreto, F. J., Novak, A. J. & Ansell, S. M., Feb 13 2014, In : Blood. 123, 7, p. 1055-1058 4 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Chemical activation
Cells
Janus Kinases
9 Citations (Scopus)

Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma

Witzig, T. E., Maurer, M. J., Habermann, T. M., Link, B. K., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Markovic, S. N., Johnston, P. B., Lin, Y., Thompson, C. A., Gupta, M., Katzmann, J. A. & Cerhan, J. R., Dec 1 2014, In : American Journal of Hematology. 89, 12, p. 1116-1120 5 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Light
Serum
2 Citations (Scopus)

Follicular lymphoma: Watch and wait is watch and worry

Ansell, S. M., 2014, In : The Lancet Oncology. 15, 4, p. 368-369 2 p.

Research output: Contribution to journalArticle

Murine-Derived Monoclonal Antibodies
Watchful Waiting
Follicular Lymphoma
Antineoplastic Agents
73 Citations (Scopus)

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Wang, T., Feldman, A. L., Wada, D. A., Lu, Y., Polk, A., Briski, R., Ristow, K., Habermann, T. M., Thomas, D., Ziesmer, S. C., Wellik, L. E., Lanigan, T. M., Witzig, T. E., Pittelkow, M. R., Bailey, N. G., Hristov, A. C., Lim, M. S., Ansell, S. M. & Wilcox, R. A., May 8 2014, In : Blood. 123, 19, p. 3007-3015 9 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
T-cells
Set theory
T-Cell Lymphoma
Carrier Proteins
4 Citations (Scopus)

Genetic diversity of newly diagnosed follicular lymphoma

Asmann, Y., Maurer, M. J., Wang, C., Sarangi, V., Ansell, S. M., Feldman, A. L., Nowakowski, G. S., Manske, M., Price-Troska, T., Yang, Z. Z., Slager, S. L., Habermann, T. M., Cerhan, J. R. & Novak, A. J., Jan 1 2014, In : Blood Cancer Journal. 4, 10, e256.

Research output: Contribution to journalArticle

Neoplasm Proteins
Follicular Lymphoma
Mutation
75 Citations (Scopus)

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Cerhan, J. R., Berndt, S. I., Vijai, J., Ghesquières, H., McKay, J., Wang, S. S., Wang, Z., Yeager, M., Conde, L., De Bakker, P. I. W., Nieters, A., Cox, D., Burdett, L., Monnereau, A., Flowers, C. R., De Roos, A. J., Brooks-Wilson, A. R., Lan, Q., Severi, G., Melbye, M. & 102 others, Gu, J., Jackson, R. D., Kane, E., Teras, L. R., Purdue, M. P., Vajdic, C. M., Spinelli, J. J., Giles, G. G., Albanes, D., Kelly, R. S., Zucca, M., Bertrand, K. A., Zeleniuch-Jacquotte, A., Lawrence, C., Hutchinson, A., Zhi, D., Habermann, T. M., Link, B. K., Novak, A. J., Dogan, A., Asmann, Y., Liebow, M., Thompson, C. A., Ansell, S. M., Witzig, T. E., Weiner, G. J., Veron, A. S., Zelenika, D., Tilly, H., Haioun, C., Molina, T. J., Hjalgrim, H., Glimelius, B., Adami, H. O., Bracci, P. M., Riby, J., Smith, M. T., Holly, E. A., Cozen, W., Hartge, P., Morton, L. M., Severson, R. K., Tinker, L. F., North, K. E., Becker, N., Benavente, Y., Boffetta, P., Brennan, P., Foretova, L., Maynadie, M., Staines, A., Lightfoot, T., Crouch, S., Smith, A., Roman, E., Diver, W. R., Offit, K., Zelenetz, A., Klein, R. J., Villano, D. J., Zheng, T., Zhang, Y., Holford, T. R., Kricker, A., Turner, J., Southey, M. C., Clavel, J., Virtamo, J., Weinstein, S., Riboli, E., Vineis, P., Kaaks, R., Trichopoulos, D., Vermeulen, R. C. H., Boeing, H., Tjonneland, A., Angelucci, E., Di Lollo, S., Rais, M., Birmann, B. M., Laden, F., Giovannucci, E., Kraft, P., Huang, J., Ma, B., Ye, Y., Chiu, B. C. H., Sampson, J., Liang, L., Park, J. H., Chung, C. C., Weisenburger, D. D., Chatterjee, N., Fraumeni, J. F., Slager, S. L., Wu, X., De Sanjose, S., Smedby, K. E., Salles, G., Skibola, C. F., Rothman, N. & Chanock, S. J., Nov 5 2014, Nature Genetics. 11 ed. Nature Publishing Group, Vol. 46. p. 1233-1238 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lymphoma, Large B-Cell, Diffuse
Genome-Wide Association Study
Single Nucleotide Polymorphism
Genetic Predisposition to Disease
Genetic Loci